Mass spectrometric based approaches in urine metabolomics and biomarker discovery

Mass Spectrometry Reviews

Volumn 36, Issue 2, 2017, Pages 115-134

  Khamis, Mona M ^a,b   Adamko, Darryl J ^c   El Aneed, Anas ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Alexandria University Faculty of Pharmacy   (Egypt)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Biomarker; Mass Spectrometry; Metabolome; Targeted; Untargeted; Urine

Indexed keywords

BIOMARKERS; BODY FLUIDS; CAPILLARY ELECTROPHORESIS; CHEMICAL ANALYSIS; CHROMATOGRAPHY; DIAGNOSIS; DIRECT INJECTION; EXTRACTION; FILTRATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; ISOTOPES; LIQUIDS; MASS SPECTROMETRY; METABOLITES; SOLVENT EXTRACTION; SPECTROMETRY;

HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHIES; LIQUID-LIQUID EXTRACTION; METABOLOMES; TARGETED; THERAPEUTIC INTERVENTION; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES; UNTARGETED; URINE;

LIQUID CHROMATOGRAPHY;

BIOLOGICAL MARKER;

ANIMAL; HUMAN; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PROCEDURES; URINALYSIS; URINE;

ANIMALS; BIOMARKERS; CHROMATOGRAPHY, LIQUID; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; URINALYSIS;

EID: 84927932397     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.21455     Document Type: Review

References (160)

1. Adamko D, Rowe BH, Marrie T, Sykes BD. 2007. Variation of metabolites in normal human urine. Metabolomics 3: 439–451.
2. Almstetter MF, Oefner PJ, Dettmer K. 2012. Comprehensive two-dimensional gas chromatography in metabolomics. Anal Bioanal Chem 402: 1993–2013.
3. Armitage EG, Barbas C. 2014. Metabolomics in cancer biomarker discovery: Current trends and future perspectives. J Pharm Biomed Anal 87:1–11.
4. Bayer E. 2001. Recent advances in capillary electrophoresis/electrospray-mass spectrometry. Electrophoresis 22:1251–1266.
5. Baños CE, Silva M. 2010. Liquid chromatography–tandem mass spectrometry for the determination of low-molecular mass aldehydes in human urine. J Chromatogr B 878: 653–658.
6. Beger RD, Holland RD, Sun J, Schnackenberg LK, Moore PC, Dent CL, Devarajan P, Portilla D. 2008. Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol 23: 977–984.
7. Begley P, Francis-McIntyre S, Dunn WB, Broadhurst DI, Halsall A, Tseng A, Knowles J, Consortium H, Goodacre R, Kell DB. 2009. Development and Performance of a Gas Chromatography − Time-of-Flight Mass Spectrometry Analysis for Large-Scale Nontargeted Metabolomic Studies of Human Serum. Anal Chem 81: 7038–7046.
8. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. 2011. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 49: 231–243.
9. Bicker W, Lämmerhofer M, Genser D, Kiss H, Lindner W. 2005. A case study of acute human chlorpyrifos poisoning: Novel aspects on metabolism and toxicokinetics derived from liquid chromatography–tandem mass spectrometry analysis of urine samples. Toxicol lett 159: 235–251.
10. Boeniger MF, Lowry LK, Rosenberg J. 1993. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: A review. Am Ind Hyg Assoc J 54: 615–627.
11. Bondia-Pons I, Barri T, Hanhineva K, Juntunen K, Dragsted LO, Mykkänen H, Poutanen K. 2013. UPLC-QTOF/MS metabolic profiling unveils urinary changes in humans after a whole grain rye versus refined wheat bread intervention. Mol Nutr Food Res 57: 412–422.
12. Boomsma F, Alberts G, Van Eijk L, Schalekamp M. 1993. Optimal collection and storage conditions for catecholamine measurements in human plasma and urine. Clin Chem 39: 2503–2508.
13. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas H, Hersch S, Hogarth P, Bouzou B, Jensen R. 2005. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102: 11023–11028.
14. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P. 2013. The human urine metabolome. PloS ONE 8: e73076.
15. Boyland E, Wallace D, Williams D. 1955. The activity of the enzymes sulphatase and β-glucuronidase in the urine, serum and bladder tissue. Br J cancer 9: 62.
16. Buszewski B, Noga S. 2012. Hydrophilic interaction liquid chromatography (HILIC)—a powerful separation technique. Anal Bioanal Chem 402: 231–247.
17. Chadha V, Garg U, Alon US. 2001. Measurement of urinary concentration: a critical appraisal of methodologies. Pediatr Nephrol 16: 374–382.
18. Chen J, Wang W, Lv S, Yin P, Zhao X, Lu X, Zhang F, Xu G. 2009. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal Chim Acta 650: 3–9.
19. Chen J-L, Huang Y-J, Pan C-H, Hu C-W, Chao M-R. 2011a. Determination of urinary malondialdehyde by isotope dilution LC-MS/MS with automated solid-phase extraction: a cautionary note on derivatization optimization. Free Radical Biol Med 51: 1823–1829.
20. Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X. 2011b. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics 10: M110. 004945.
21. Cho S-H, Choi MH, Lee W-Y, Chung BC. 2009. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. Clin Biochem 42: 540–543.
22. Clarke DB, Lloyd AS, Botting NP, Oldfield MF, Needs PW, Wiseman H. 2002. Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C3] isoflavone internal standards. Anal Biochem 309: 158–172.
23. Cone EJ, Caplan YH, Moser F, Robert T, Shelby MK, Black DL. 2009. Normalization of urinary drug concentrations with specific gravity and creatinine. J Anal Toxicol 33: 1–7.
24. Dai W, Huang Q, Yin P, Li J, Zhou J, Kong H, Zhao C, Lu X, Xu G. 2012. Comprehensive and highly sensitive urinary steroid hormone profiling method based on stable isotope-labeling liquid chromatography–mass spectrometry. Anal Chem 84: 10245–10251.
25. Dettmer K, Aronov PA, Hammock BD. 2007. Mass spectrometry-based metabolomics. Mass Spectrom Rev 26: 51–78.
26. Dunn WB. 2008. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys biol 5: 011001.
27. Dunn WB, Broadhurst D, Ellis DI, Brown M, Halsall A, O'Hagan S, Spasic I, Tseng A, Kell DB. 2008. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. International journal of epidemiology 37: i23–i30.
28. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. 2011. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40: 387–426.
29. Dunn WB, Ellis DI. 2005. Metabolomics: current analytical platforms and methodologies. TrAC. Trends Anal Chem 24: 285–294.
30. Dunn WB, Erban A, Weber RJ, Creek DJ, Brown M, Breitling R, Hankemeier T, Goodacre R, Neumann S, Kopka J. 2013. Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9: 44–66.
31. Eggink M, Wijtmans M, Ekkebus R, Lingeman H, de Esch IJP, Kool J, Niessen WM, Irth H. 2008. Development of a selective ESI-MS derivatization reagent: synthesis and optimization for the analysis of aldehydes in biological mixtures. Anal chem 80: 9042–9051.
32. Eggink M, Wijtmans M, Kretschmer A, Kool J, Lingeman H, de Esch IJP, Niessen WM, Irth H. 2010. Targeted LC–MS derivatization for aldehydes and carboxylic acids with a new derivatization agent 4-APEBA. Anal Bioanal Chem 397: 665–675.
33. Fernández-Peralbo M, Luque de Castro M. 2012. Preparation of urine samples prior to targeted or untargeted metabolomics mass-spectrometry analysis. TrAC. Trends Anal Chem 41:75–85.
34. Fiehn O, Kopka J, Dörmann P, Altmann T, Trethewey RN, Willmitzer L. 2000. Metabolite profiling for plant functional genomics. Nat biotechnol 18: 1157–1161.
35. Fiehn O, Robertson D, Griffin J, van der Werf M, Nikolau B, Morrison N, Sumner LW, Goodacre R, Hardy NW, Taylor C. 2007. The metabolomics standards initiative (MSI). Metabolomics 3: 175–178.
36. Gangl ET, Annan M, Spooner N, Vouros P. 2001. Reduction of signal suppression effects in ESI-MS using a nanosplitting device. Anal chem 73: 5635–5644.
37. Gika HG, Theodoridis GA, Wilson ID. 2008a. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. J Sep Sci 31: 1598–1608.
38. Gika HG, Theodoridis GA, Wilson ID. 2008b. Liquid chromatography and ultra-performance liquid chromatography–mass spectrometry fingerprinting of human urine: Sample stability under different handling and storage conditions for metabonomics studies. J Chromatogr A 1189: 314–322.
39. Gowda GN, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. 2008. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 8: 617–633.
40. Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP. 2010. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed 49: 5426–5445.
41. Guo B, Chen B, Liu A, Zhu W, Yao S. 2012. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics. Curr Drug Metab 13: 1226–1243.
42. Guo K, Ji C, Li L. 2007. Stable-isotope dimethylation labeling combined with LC-ESI MS for quantification of amine-containing metabolites in biological samples. Anal chem 79: 8631–8638.
43. Guo K, Li L. 2009. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal chem 81: 3919–3932.
44. Guo K, Li L. 2010. High-performance isotope labeling for profiling carboxylic acid-containing metabolites in biofluids by mass spectrometry. Anal chem 82: 8789–8793.
45. Halket JM, Waterman D, Przyborowska AM, Patel RK, Fraser PD, Bramley PM. 2005. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot 56: 219–243.
46. Han J, Danell RM, Patel JR, Gumerov DR, Scarlett CO, Speir JP, Parker CE, Rusyn I, Zeisel S, Borchers CH. 2008. Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics 4: 128–140.
47. Hasegawa M, Takenaka S, Kuwamura M, Yamate J, Tsuyama S. 2007. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS. Exp Toxicol Pathol 59: 115–120.
48. Hayama T, Sakaguchi Y, Yoshida H, Itoyama M, Todoroki K, Yamaguchi M, Nohta H. 2010. Fluorous derivatization combined with liquid chromatography/tandem mass spectrometry: a method for the selective and sensitive determination of sialic acids in biological samples. Rapid Commun Mass Spectrom 24: 2868–2874.
49. Heavner DL, Morgan WT, Sears SB, Richardson JD, Byrd GD, Ogden MW. 2006. Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines. J Pharm Biomed Anal 40: 928–942.
50. Hee SQ. 1993. Biological monitoring: an introduction. New York: John Wiley & Sons p 141.
51. Hodson MP, Dear GJ, Griffin JL, Haselden JN. 2009. An approach for the development and selection of chromatographic methods for high-throughput metabolomic screening of urine by ultra pressure LC-ESI-ToF-MS. Metabolomics 5: 166–182.
52. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA. 2008. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396–400.
53. Hsu W-Y, Lin W-D, Tsai Y, Lin C-T, Wang H-C, Jeng L-B, Lee C-C, Lin Y-C, Lai C-C, Tsai F-J. 2011. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 412: 1861–1866.
54. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J. 2007. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 56: 3588–3600.
55. Ito K, Kanada N, Inoue T, Furukawa K, Yamashita K, Tanaka N, Nakamura KT, Nishiya Y, Sogabe A, Yoshimoto T. 2002. Preliminary crystallographic studies of the creatinine amidohydrolase from Pseudomonas putida. Acta Crystallogr Sect D: Biol Crystallogr 58: 2180–2181.
56. Jacob P, Wilson M, Yu L, Mendelson J, Jones RT. 2002. Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry. Anal chem 74: 5290–5296.
57. Jain K. 2010. The handbook of Biomarkers. New York: Springer p pp p 10–11.
58. Jeng LB, Lo WY, Hsu WY, Lin WD, Lin CT, Lai CC, Tsai FJ. 2009. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis. Rapid Commun Mass Spectrom 23: 1543–1549.
59. Johnson CH, Gonzalez FJ. 2012. Challenges and opportunities of metabolomics. J Cell Physiol 227: 2975–2981.
60. Jung K, Pergande M. 1983. Particulate and free enzyme activity in urine as a result of the shedding of brush-border membranes from kidney. Clin Chim 29: 392–393.
61. Katajamaa M, Orešič M. 2007. Data processing for mass spectrometry-based metabolomics. J Chromatogr A 1158: 318–328.
62. Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH. 2011. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS 15: 293–303.
63. Kirwan J, Broadhurst D, Davidson R, Viant M. 2013. Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow. Anal Bioanal Chem 405: 5147–5157.
64. Kirwan JA, Weber RJ, Broadhurst DI, Viant MR. 2014. Direct infusion mass spectrometry metabolomics dataset: a benchmark for data processing and quality control. Scientific Data 1.
65. Kretschmer A, Giera M, Wijtmans M, De Vries L, Lingeman H, Irth H, Niessen W. 2011. Derivatization of carboxylic acids with 4-APEBA for detection by positive-ion LC-ESI–MS (/MS) applied for the analysis of prostanoids and NSAID in urine. J Chromatogr B 879: 1393–1401.
66. Kuehnbaum NL, Britz-McKibbin P. 2011. Comprehensive profiling of free and conjugated estrogens by capillary electrophoresis–time of flight/mass spectrometry. Anal chem 83: 8063–8068.
67. Kuklenyik Z, Ashley DL, Calafat AM. 2002. Quantitative detection of trichloroacetic acid in human urine using isotope dilution high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Anal chem 74: 2058–2063.
68. Kumar BS, Chung BC, Kwon OS, Jung BH. 2012. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J Appl Toxicol 32: 505–520.
69. Kumar BS, Chung BC, Lee Y-J, Yi HJ, Lee B-H, Jung BH. 2011. Gas chromatography–mass spectrometry-based simultaneous quantitative analytical method for urinary oxysterols and bile acids in rats. Anal Biochem 408: 242–252.
70. Kumar BS, Lee Y-J, Yi HJ, Chung BC, Jung BH. 2010. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Anal Chim Acta 661: 47–59.
71. Lafaye A, Junot C, Gall RL, Fritsch P, Ezan E, Tabet JC. 2004. Profiling of sulfoconjugates in urine by using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats. J Mass Spectrom 39: 655–664.
72. Lauridsen M, Hansen SH, Jaroszewski JW, Cornett C. 2007. Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage. Anal chem 79: 1181–1186.
73. Lei Z, Huhman DV, Sumner LW. 2011. Mass spectrometry strategies in metabolomics. J Biol Chem 286: 25435–25442.
74. Levine L, Fahy JP. 1945. Evaluation of urinary lead concentrations. I. The significance of the specific gravity. J Ind Hyg Toxicol 27:217–223.
75. Lu W, Bennett BD, Rabinowitz JD. 2008. Analytical strategies for LC–MS-based targeted metabolomics. J Chromatogr B 871: 236–242.
76. Martínez-Lozano P, Rus J. 2010. Separation of isomers l-alanine and sarcosine in urine by electrospray ionization and tandem differential mobility analysis-mass spectrometry. J Am Soc Mass Spectrom 21: 1129–1132.
77. Mikami T, Aoki M, Kimura T. 2012. The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development. Curr Mol Pharmacol 5: 301–316.
78. Miller RC, Brindle E, Holman DJ, Shofer J, Klein NA, Soules MR, O'Connor KA. 2004. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin chem 50: 924–932.
79. Monteiro M, Carvalho M, Bastos M, Guedes de Pinho P. 2013. Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem 20: 257–271.
80. Moon J-Y, Jung H-J, Moon MH, Chung BC, Choi MH. 2009. Heat-map visualization of gas chromatography-mass spectrometry based quantitative signatures on steroid metabolism. J Am Soc Mass Spectrom 20: 1626–1637.
81. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C. 2008. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study. Lancet Oncol 9: 359–366.
82. Nam H, Chung BC, Kim Y, Lee K, Lee D. 2009. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 25: 3151–3157.
83. Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, Chiong E, Chan ECY. 2010. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res 9: 2988–2995.
84. Patti GJ, Yanes O, Siuzdak G. 2012. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13: 263–269.
85. Peng J, Li L. 2013. Liquid–liquid extraction combined with differential isotope dimethylaminophenacyl labeling for improved metabolomic profiling of organic acids. Anal Chim Acta 803:97–105.
86. Pesek JJ, Matyska MT, Fischer SM, Sana TR. 2008. Analysis of hydrophilic metabolites by high-performance liquid chromatography–mass spectrometry using a silica hydride-based stationary phase. J Chromatogr A 1204: 48–55.
87. Pesek JJ, Matyska MT, Loo JA, Fischer SM, Sana TR. 2009. Analysis of hydrophilic metabolites in physiological fluids by HPLC-MS using a silica hydride-based stationary phase. J Sep Sci 32: 2200–2208.
88. Pigini D, Cialdella A, Faranda P, Tranfo G. 2006. Comparison between external and internal standard calibration in the validation of an analytical method for 1-hydroxypyrene in human urine by high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 20: 1013–1018.
89. Pinto-Sietsma S-J, Janssen WM, Hillege HL, Navis G, de Zeeuw D, de Jong PE. 2000. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11: 1882–1888.
90. Plumb RS, Granger JH, Stumpf CL, Johnson KA, Smith BW, Gaulitz S, Wilson ID, Castro-Perez J. 2005. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130: 844–849.
91. Plumb RS, Stumpf CL, Granger JH, Castro-Perez J, Haselden JN, Dear GJ. 2003. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun Mass Spectrom 17: 2632–2638.
92. Putluri N, Shojaie A, Vasu VT, Vareed SK, Nalluri S, Putluri V, Thangjam GS, Panzitt K, Tallman CT, Butler C. 2011. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer research 71: 7376–7386.
93. Ramautar R, Mayboroda OA, Somsen GW, de Jong GJ. 2011. CE-MS for metabolomics: Developments and applications in the period 2008–2010. Electrophoresis 32: 52–65.
94. Ramautar R, Somsen GW, de Jong GJ. 2009. CE-MS in metabolomics. Electrophoresis 30: 276–291.
95. Ramautar R, Somsen GW, de Jong GJ. 2013. CE-MS for metabolomics: Developments and applications in the period 2010–2012. Electrophoresis 34: 86–98.
96. Remer T, Boye KR, Hartmann MF, Wudy SA. 2005. Urinary markers of adrenarche: reference values in healthy subjects, aged 3–18 years. J Clin Endocrinol Metab 90: 2015–2021.
97. Rijk JC, Lommen A, Essers ML, Groot MJ, Van Hende JM, Doeswijk TG, Nielen MW. 2009. Metabolomics approach to anabolic steroid urine profiling of bovines treated with prohormones. Anal chem 81: 6879–6888.
98. Roberts LD, Souza AL, Gerszten RE, Clish CB. 2012. Targeted metabolomics. Current Protocols in Molecular Biology. 30. 32. 31–30. 32. 24.
99. Rocha SM, Caldeira M, Carrola J, Santos M, Cruz N, Duarte IF. 2012. Exploring the human urine metabolomic potentialities by comprehensive two-dimensional gas chromatography coupled to time of flight mass spectrometry. J Chromatogr A 1252:155–163.
100. Roux A, Lison D, Junot C, Heilier J-F. 2011. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. Clin Biochem 44: 119–135.
101. Ryan D, Robards K, Prenzler P, Kendall M. 2011. Recent and potential developments in the analysis of urine: a review. Anal Chim Acta 684: 17–29.
102. Santa T. 2013. Derivatization in liquid chromatography for mass spectrometric detection. Drug Discoveries Ther 7:(1).
103. Saude EJ, Obiefuna IP, Somorjai RL, Ajamian F, Skappak C, Ahmad T, Dolenko BK, Sykes BD, Moqbel R, Adamko DJ. 2009. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. Am J Respir Crit Care Med 179: 25–34.
104. Saude EJ, Skappak CD, Regush S, Cook K, Ben-Zvi A, Becker A, Moqbel R, Sykes BD, Rowe BH, Adamko DJ. 2011. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 127: 757–764. e756.
105. Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S. 2009. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 5: 435–458.
106. Schram KH. 1998. Urinary nucleosides. Mass Spectrom Rev 17: 131–251.
107. Seiwert B, Karst U. 2007. Simultaneous LC/MS/MS determination of thiols and disulfides in urine samples based on differential labeling with ferrocene-based maleimides. Anal chem 79: 7131–7138.
108. Shama N, Bai SW, Chung BC, Jung BH. 2008. Quantitative analysis of 17 amino acids in the connective tissue of patients with pelvic organ prolapse using capillary electrophoresis–tandem mass spectrometry. J Chromatogr B 865: 18–24.
109. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S. 2007. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal chem 79: 6995–7004.
110. Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T. 2003. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res 2: 488–494.
111. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910–914.
112. Stokvis E, Rosing H, López-Lázaro L, Schellens J, Beijnen J. 2004. Switching from an analogous to a stable isotopically labeled internal standard for the LC-MS/MS quantitation of the novel anticancer drug Kahalalide F significantly improves assay performance. Biomed Chromatogr 18: 400–402.
113. Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R. 2012. Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr 142: 14–21.
114. Struck W, Siluk D, Yumba-Mpanga A, Markuszewski M, Kaliszan R, Markuszewski MJ. 2013. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers. J Chromatogr A 1283:122–131.
115. Struys E, Jansen E, Gibson K, Jakobs C. 2005. Determination of the GABA analogue succinic semialdehyde in urine and cerebrospinal fluid by dinitrophenylhydrazine derivatization and liquid chromatography–tandem mass spectrometry: application to SSADH deficiency. J Inherited Metab Dis 28: 913–920.
116. Sykes BD. 2007. Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics 3: 19–27.
117. Theodoridis G, Gika HG, Wilson ID. 2011. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom Rev 30: 884–906.
118. Theodoridis GA, Gika HG, Want EJ, Wilson ID. 2012. Liquid chromatography–mass spectrometry based global metabolite profiling: a review. Anal Chim Acta 711:7–16.
119. Toyo'oka T. 2012. LC–MS determination of bioactive molecules based upon stable isotope-coded derivatization method. J Pharm Biomed Anal 69:174–184.
120. Trivedi DK, Iles RK. 2014a. Do not just do it, do it right: urinary metabolomics–establishing clinically relevant baselines. Biomed Chromatogr DOI: 10.1002/bmc.3219
121. Trivedi DK, Iles RK. 2014b. HILIC-MS-based shotgun metabolomic profiling of maternal urine at 9–23 weeks of gestation–establishing the baseline changes in the maternal metabolome. Biomed Chromatogr DOI: 10.1002/bmc.3266
122. Trivedi DK, Jones H, Shah A, Iles RK. 2012. Development of Zwitterionic Hydrophilic Liquid Chromatography (ZIC®HILIC-MS) Metabolomics Method for Shotgun Analysis of Human Urine. J Chromatogr Sep Tech 3: 144.
123. Turowski M, Yamakawa N, Meller J, Kimata K, Ikegami T, Hosoya K, Tanaka N, Thornton ER. 2003. Deuterium isotope effects on hydrophobic interactions: the importance of dispersion interactions in the hydrophobic phase. J Am Chem Soc 125: 13836–13849.
124. Tyburski JB, Patterson AD, Krausz KW, Slavík J, Fornace AJ, Jr, Gonzalez FJ, Idle JR. 2009. Radiation metabolomics. 2. Dose-and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiation research 172: 42–57.
125. Udert KM, Larsen TA, Biebow M, Gujer W. 2003. Urea hydrolysis and precipitation dynamics in a urine-collecting system. Water Research 37: 2571–2582.
126. Urpi-Sarda M, Monagas M, Khan N, Llorach R, Lamuela-Raventós RM, Jáuregui O, Estruch R, Izquierdo-Pulido M, Andrés-Lacueva C. 2009. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography–tandem mass spectrometry. J Chromatogr A 1216: 7258–7267.
127. van de Merbel NC. 2008. Quantitative determination of endogenous compounds in biological samples using chromatographic techniques. TrAC. Trends Anal Chem 27: 924–933.
128. Van Doorn M, Vogels J, Tas A, Van Hoogdalem EJ, Burggraaf J, Cohen A, Van Der Greef J. 2007. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol 63: 562–574.
129. Van QN, Veenstra TD, Issaq HJ. 2011. Metabolic profiling for the detection of bladder cancer. Curr Urol Rep 12: 34–40.
130. Viau C, Lafontaine M, Payan J. 2004. Creatinine normalization in biological monitoring revisited: the case of 1-hydroxypyrene. Int Arch Occup Environ Health 77: 177–185.
131. Villas-Bôas SG, Smart KF, Sivakumaran S, Lane GA. 2011. Alkylation or silylation for analysis of amino and non-amino organic acids by GC-MS?. Metabolites 1: 3–20.
132. Vuckovic D. 2012. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Anal Bioanal Chem 403: 1523–1548.
133. Wade D. 1999. Deuterium isotope effects on noncovalent interactions between molecules. Chem-Biol Interact 117: 191–217.
134. Wagner S, Scholz K, Donegan M, Burton L, Wingate J, Völkel W. 2006. Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Anal chem 78: 1296–1305.
135. Wang X, Sun H, Zhang A, Wang P, Han Y. 2011. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci 34: 3451–3459.
136. Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, Dong T, Yuan Y, Yuan X, Zhang M. 2012. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 11: 370–380.
137. Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, Shockcor J, Holmes E, Nicholson JK. 2010. Global metabolic profiling procedures for urine using UPLC–MS. Nat Protoc 5: 1005–1018.
138. Warrack BM, Hnatyshyn S, Ott K-H, Reily MD, Sanders M, Zhang H, Drexler DM. 2009. Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B 877: 547–552.
139. Weimann A, Belling D, Poulsen HE. 2002. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography–electrospray tandem mass spectrometry. Nucleic Acids Res 30: e7–e7.
140. Williams DM, Sreedhar SS, Mickell JJ, Chan JC. 2002. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med 156: 893–900.
141. Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW, Plumb RS. 2005. High resolution “ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 4: 591–598.
142. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E. 2013. HMDB 3. 0—the human metabolome database in 2013. Nucleic Acids Res 41: D801–D807.
143. Wittke S, Fliser D, Haubitz M, Bartel S, Krebs R, Hausadel F, Hillmann M, Golovko I, Koester P, Haller H. 2003. Determination of peptides and proteins in human urine with capillary electrophoresis–mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr A 1013: 173–181.
144. Wojtowicz P, Zrostlíková J, Kovalczuk T, Schůrek J, Adam T. 2010. Evaluation of comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry for the diagnosis of inherited metabolic disorders using an automated data processing strategy. J Chromatogr A 1217: 8054–8061.
145. Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC. 2009. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta 400: 63–69.
146. Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, Shen X. 2009. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta 648: 98–104.
147. Wu Y, Li L. 2012. Determination of Total Concentration of Chemically Labeled Metabolites as a Means of Metabolome Sample Normalization and Sample Loading Optimization in Mass Spectrometry-Based Metabolomics. Anal chem 84: 10723–10731.
148. Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, Saavedra JE, Keefer LK, Ziegler RG. 2005. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal chem 77: 6646–6654.
149. Xu X, Ziegler RG, Waterhouse DJ, Saavedra JE, Keefer LK. 2002. Stable isotope dilution high-performance liquid chromatography–electrospray ionization mass spectrometry method for endogenous 2-and 4-hydroxyestrones in human urine. J Chromatogr B 780: 315–330.
150. Yamashita K, Nakagawa R, Okuyama M, Honma S, Takahashi M, Numazawa M. 2008. Simultaneous determination of tetrahydrocortisol, allotetrahydrocortisol and tetrahydrocortisone in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 73: 727–737.
151. Yang WC, Regnier FE, Adamec J. 2008. Comparative metabolite profiling of carboxylic acids in rat urine by CE-ESI MS/MS through positively pre-charged and 2H-coded derivatization. Electrophoresis 29: 4549–4560.
152. Zeisel SH, DaCosta KA, Fox JG. 1985. Endogenous formation of dimethylamine. Biochem J 232:403–408.
153. Zhang A, Sun H, Wang P, Han Y, Wang X. 2012a. Modern analytical techniques in metabolomics analysis. Analyst 137: 293–300.
154. Zhang A, Sun H, Wu X, Wang X. 2012b. Urine metabolomics. Clin Chim Acta 414:65–69.
155. Zhang T, Creek DJ, Barrett MP, Blackburn G, Watson DG. 2012c. Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine. Anal chem 84: 1994–2001.
156. Zhang Z, Bast RC, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng X-Y. 2004. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer research 64: 5882–5890.
157. Zheng J, Li L. 2012. Fragmentation of protonated dansyl-labeled amines for structural analysis of amine-containing metabolites. International J Mass Spectrom 316:292–299.
158. Zheng S, Yu M, Lu X, Huo T, Ge L, Yang J, Wu C, Li F. 2010. Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression. Clin Chim Acta 411: 204–209.
159. Zhou R, Guo K, Li L. 2013. 5-Diethylamino-naphthalene-1-sulfonyl Chloride (DensCl): A novel triplex isotope labeling reagent for quantitative metabolome analysis by liquid chromatography mass spectrometry. Anal chem 85: 11532–11539.
160. Zhou R, Tseng C-L, Huan T, Li L. 2014. IsoMS: Automated Processing of LC-MS Data Generated by a Chemical Isotope Labeling Metabolomics Platform. Anal chem 86: 4675–4679.